Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn about the credit cards that provide the best cash back and points potential. Unlock the rewards that suit your spending habits.
28,655 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A country star’s lighthearted single sparks a conversation about AI, creativity, and the real-world finance behind mu...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Account takeovers threaten every investor. This guide breaks down what customer account takeovers: what they mean for...
Jumia's Q1 2026 earnings call offers a clear view of how the company plans to scale across Africa. This article break...
Bitcoin is showing notable strength with a 3.7% rise in a single session. This piece breaks down the catalysts behind...
The auto parts sector posted a strong year with a 42% rally, but a prominent investor pulled the trigger on a multi-m...
A major TV move—Jennifer Aniston reportedly exits an Apple series—highlights how gig income, contracts, and risk affe...
Two AI hardware names—Astera Labs and Navitas Semiconductor—shine for investors through very different revenue paths....
AI-driven data centers are reshaping memory supply. This article breaks down what data centers will consume for memor...
The AI rally cooled, but the opportunity remains. This guide shares three AI stocks investors should load up on and a...
The Trade Desk is testing a strategy that could redefine cross-platform audience reach. Audience Unlimited Could Trad...